Suchergebnisse - "Peters, Björn"

PubPharm (163)

1

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort study

enthalten in: bioRxiv.org | 2024

von Staessen, J. | Wendt, R. | Yu, Y. | +36

2

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health

enthalten in: Frontiers in cardiovascular medicine | 2024

von Harlacher, E. | Schulte, C. | Vondenhoff, S. | +16

3

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Peters, B. | Beige, J. | Siwy, J. | +38

4

Critical COVID-19 represents an endothelial disease with high similarity to kidney disease on the molecular level

enthalten in: bioRxiv.org | 2023

von Siwy, J. | Wendt, R. | Albalat, A. | +14

5

Sex-specific time trends of long-term graft survival after kidney transplantation - a registry-based study

enthalten in: Renal failure | 2023

von Nasic, S. | Peters, B. | Stegmayr, B. | +3

6

Transvenous lead extraction in children with bidirectional rotational dissection sheaths

enthalten in: Frontiers in cardiovascular medicine | 2023

von Heck, R. | Peters, B. | Lanmüller, P. | +5

7

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy

enthalten in: Nephrology, dialysis, transplantation | 2023

von Peters, B. | Beige, J. | Siwy, J. | +12

8

Glomerular macrophage index (GMI) in kidney transplant biopsies is associated with graft outcome

enthalten in: Clinical transplantation | 2022

von Mölne, J. | Nasic, S. | Bröcker, V. | +3

9

High-resolution African HLA resource uncoversHLA-DRB1expression effects underlying vaccine response

enthalten in: bioRxiv.org | 2022

von Mentzer, A. | Dilthey, A. | Pollard, M. | +42

10

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection : a prospective multicentre cohort study

enthalten in: The Lancet. Digital health | 2022

von Staessen, J. | Wendt, R. | Yu, Y. | +119

ErratumIn: Lancet Digit Health. 2023 Feb;5(2):e58. - PMID 36528543

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]